[Mortality and cause of death in schizophrenia. Review of the literature]
- PMID: 8275890
[Mortality and cause of death in schizophrenia. Review of the literature]
Abstract
Through a review of the literature, the average mortality in schizophrenia is twice higher than among the population. This over mortality is highest among the 20-40 years range of age and added risk tends to disappear after 60 years. All studies stress the unnatural causes of death, suicide or accidental deaths. However several studies found an over mortality caused by natural death. The pathologies most often involved are: infections, lung, gastrointestinal, urogenital and cardiovascular diseases. Cancer mortality in schizophrenic patients is still debated. Some studies point out a reduced mortality compared to the general population whereas other studies find similar or over mortality. Nevertheless mortality ratio is found to be near 1 in the majority of studies. So it can be admitted that schizophrenic patient do really not differ from the general population in regard to cancer mortality. Premature death is highly linked to suicide. The epidemiological indicators that enable us to estimate the importance of suicide mortality are: the rate of suicide per 105 patients per year varies between 150 and 500, the percentage of death by suicide range between 10 and 15 percent. Suicide risk factors are numerous. Some of them are accepted as valid and others are still discussed. The former are: male gender, young and medium age ten first years of the illness course, associated depressive symptoms, past history of suicide attempts, iterative relapses and post hospital discharge period. The latter are: social isolation, celibacy, unemployment, high level of instruction, delusional and hallucinatory activity and familiar rejection.
Similar articles
-
[Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].Encephale. 2000 Nov-Dec;26(6):32-41. Encephale. 2000. PMID: 11217537 French.
-
[Mortality among chronic schizophrenic patients: a prospective 14-year follow-up study of 150 schizophrenic patients].Encephale. 2008 Jan;34(1):54-60. doi: 10.1016/j.encep.2007.07.005. Epub 2007 Sep 5. Encephale. 2008. PMID: 18514151 French.
-
[Mortality of patients with functional psychiatric illnesses during inpatient treatment].Fortschr Neurol Psychiatr. 1997 Apr;65(4):171-81. doi: 10.1055/s-2007-996320. Fortschr Neurol Psychiatr. 1997. PMID: 9235309 German.
-
Mortality in schizophrenia.Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1308-12. doi: 10.1002/pds.1496. Pharmacoepidemiol Drug Saf. 2007. PMID: 17944000 Review.
-
Mortality in schizophrenia.Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):873-9. doi: 10.1002/pds.1325. Pharmacoepidemiol Drug Saf. 2006. PMID: 17058327 Review.
Cited by
-
Risperidone. A pharmacoeconomic review of its use in schizophrenia.Pharmacoeconomics. 1998 Jul;14(1):97-133. doi: 10.2165/00019053-199814010-00009. Pharmacoeconomics. 1998. PMID: 10182198 Review.
-
Measuring the costs of schizophrenia. Implications for the post-institutional era in the US.Pharmacoeconomics. 1995 Sep;8(3):199-222. doi: 10.2165/00019053-199508030-00004. Pharmacoeconomics. 1995. PMID: 10155617 Review.
-
Double disparities in the health care for people with schizophrenia of an ethnic-national minority.Isr J Health Policy Res. 2017 Oct 15;6(1):47. doi: 10.1186/s13584-017-0166-z. Isr J Health Policy Res. 2017. PMID: 29031281 Free PMC article.
-
Health care disparities among persons with comorbid schizophrenia and cardiovascular disease: a case-control epidemiological study.Epidemiol Psychiatr Sci. 2016 Dec;25(6):541-547. doi: 10.1017/S2045796015000852. Epub 2015 Oct 1. Epidemiol Psychiatr Sci. 2016. PMID: 26423605 Free PMC article.
-
Direct costs of schizophrenia in Italian community psychiatric services.Pharmacoeconomics. 2001;19(12):1217-25. doi: 10.2165/00019053-200119120-00004. Pharmacoeconomics. 2001. PMID: 11772157
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous